IR promotes fibrosis progression in the liver of patients with HCV through development of hepatic steatosis, hyperleptinemia, increased TNF production and reduced expression of peroxisome proliferator activated receptors (PPAR ץ receptors) [27,33]. The gene discussed is TNF; the disease is Hepatic steatosis.